Yifeng Pharmacy (603939) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.055x

Based on the latest financial reports, Yifeng Pharmacy (603939) has a cash flow conversion efficiency ratio of 0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥641.93 Million ≈ $93.93 Million USD) by net assets (CN¥11.66 Billion ≈ $1.71 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 603939 equity to assets ratio to measure how much of total assets are equity-financed.

Yifeng Pharmacy - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Yifeng Pharmacy's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603939 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Yifeng Pharmacy Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Yifeng Pharmacy ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Societe LDC SA PA:LOUP	0.091x
Archer Aviation Inc NYSE:ACHR	-0.072x
Science Applications International Corporation Common Stock NASDAQ:SAIC	0.172x
Centerra Gold Inc TO:CG	0.056x
OPENLANE, Inc. NYSE:OPLN	0.103x
Transcend Information Inc TW:2451	0.025x
China Southern Power Grid Technology Co Ltd SHG:688248	0.024x
Vontobel Holding SW:VONN	0.544x

Annual Cash Flow Conversion Efficiency for Yifeng Pharmacy (2011–2024)

The table below shows the annual cash flow conversion efficiency of Yifeng Pharmacy from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Yifeng Pharmacy market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥11.39 Billion ≈ $1.67 Billion	CN¥4.22 Billion ≈ $617.70 Million	0.370x	-17.00%
2023-12-31	CN¥10.45 Billion ≈ $1.53 Billion	CN¥4.66 Billion ≈ $682.38 Million	0.446x	+3.86%
2022-12-31	CN¥9.12 Billion ≈ $1.33 Billion	CN¥3.92 Billion ≈ $573.66 Million	0.430x	+57.21%
2021-12-31	CN¥7.86 Billion ≈ $1.15 Billion	CN¥2.15 Billion ≈ $314.61 Million	0.273x	+18.34%
2020-12-31	CN¥5.78 Billion ≈ $846.10 Million	CN¥1.34 Billion ≈ $195.45 Million	0.231x	+12.93%
2019-12-31	CN¥4.71 Billion ≈ $689.07 Million	CN¥963.23 Million ≈ $140.95 Million	0.205x	+67.01%
2018-12-31	CN¥4.17 Billion ≈ $610.18 Million	CN¥510.71 Million ≈ $74.73 Million	0.122x	+22.77%
2017-12-31	CN¥3.18 Billion ≈ $465.28 Million	CN¥317.20 Million ≈ $46.42 Million	0.100x	+112.11%
2016-12-31	CN¥2.98 Billion ≈ $435.39 Million	CN¥139.94 Million ≈ $20.48 Million	0.047x	-63.22%
2015-12-31	CN¥1.42 Billion ≈ $207.70 Million	CN¥181.52 Million ≈ $26.56 Million	0.128x	-64.12%
2014-12-31	CN¥595.76 Million ≈ $87.18 Million	CN¥212.35 Million ≈ $31.07 Million	0.356x	+14.22%
2013-12-31	CN¥502.20 Million ≈ $73.49 Million	CN¥156.71 Million ≈ $22.93 Million	0.312x	+64.60%
2012-12-31	CN¥425.82 Million ≈ $62.31 Million	CN¥80.73 Million ≈ $11.81 Million	0.190x	-45.08%
2011-12-31	CN¥356.28 Million ≈ $52.14 Million	CN¥122.99 Million ≈ $18.00 Million	0.345x	--

About Yifeng Pharmacy

SHG:603939 China Pharmaceutical Retailers

Market Cap

$3.99 Billion

CN¥27.24 Billion CNY

Market Cap Rank

#4118 Global

#622 in China

Share Price

CN¥22.47

Change (1 day)

-0.66%

52-Week Range

CN¥17.98 - CN¥26.22

All Time High

CN¥967.78